{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Drug Updates and Approvals: 2014 in Review
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide information about several drugs recently approved by the FDA.Learning Objectives
After completing this continuing education activity you will be able to:
- State the indications and prescribing parameters for eight new drugs.
- Identify monitoring parameters and patient instructions for these drugs.
Disclosures
The author and planners have disclosed no potential conflicts of interest, financial or otherwise.
Price:
$27.95
Credits:
- ANCC 3.0 CH / 3.0 APH
- DC - BON 3.0 CH
- FL - BON 3.0 CH
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.--------------------------------------------------This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.
Awarded Advanced Pharmacology Hours
Awarded Advanced Pharmacology Hours
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: NP1214B
Published: Dec 2014
Expires: 1/1/2026
Required Passing Score: 13/18 (72%)
Specialties:
Primary Care